Details for New Drug Application (NDA): 075315
NDA 075315 describes AMIODARONE HYDROCHLORIDE, which is a drug marketed by Acella, Bedford, Bedford Labs, Ben Venue, Dr Reddys, Epic Pharma Llc, Eugia Pharma, Fresenius Kabi Usa, Gland Pharma Ltd, Hikma Farmaceutica, Hospira, Intl Medication Sys, Mylan Institutional, Par Sterile Products, Zhejiang Poly Pharm, Aurobindo Pharma Ltd, Chartwell Rx, Dr Reddys Labs Sa, Pharmobedient, Rubicon Research, Taro, Teva, Teva Pharms, Unichem, Upsher Smith Labs, and Zydus Pharms Usa Inc, and is included in thirty-one NDAs. It is available from thirty suppliers. Additional details are available on the AMIODARONE HYDROCHLORIDE profile page.
The generic ingredient in AMIODARONE HYDROCHLORIDE is amiodarone hydrochloride. There is one drug master file entry for this compound. Thirty-three suppliers are listed for this compound. Additional details are available on the amiodarone hydrochloride profile page.
The generic ingredient in AMIODARONE HYDROCHLORIDE is amiodarone hydrochloride. There is one drug master file entry for this compound. Thirty-three suppliers are listed for this compound. Additional details are available on the amiodarone hydrochloride profile page.
Summary for 075315
| Tradename: | AMIODARONE HYDROCHLORIDE |
| Applicant: | Upsher Smith Labs |
| Ingredient: | amiodarone hydrochloride |
| Patents: | 0 |
Medical Subject Heading (MeSH) Categories for 075315
Profile for product number 001
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | TABLET;ORAL | Strength | 200MG | ||||
| Approval Date: | Dec 23, 1998 | TE: | RLD: | No | |||||
Profile for product number 002
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | TABLET;ORAL | Strength | 400MG | ||||
| Approval Date: | Jun 30, 2000 | TE: | RLD: | No | |||||
Complete Access Available with Subscription
